SALT LAKE CITY, July 22, 2010 (GLOBE NEWSWIRE) -- In the second calendar quarter (2Q) and first half (1H) of 2010, Utah Medical Products, Inc.'s (Nasdaq:UTMD) changes in financial results compared to the same time period in the prior calendar year were as follows:
2Q (April – June) 1H (January – June) Sales: -- -- Gross Profit: ( 2%) ( 4%) Operating Income: ( 1%) ( 4%) Net Income: ( 2%) ( 3%) Earnings Per Share: ( 3%) ( 4%)
In 2Q 2010 and 1H 2010, UTMD achieved the following profit margins:
|2Q 2010 (April – June)||1H 2010 (January – June)|
|Gross Profit Margin (gross profits/ sales):||52.1%||51.8%|
|Operating Profit Margin (operating profits/ sales):||35.0%||35.3%|
|Net Profit Margin (profit after taxes/ sales):||23.4%||23.6%|
Sales. Comparing 2Q 2010 to 2Q 2009 global sales in product categories, blood pressure monitoring device/ components (BPM) sales were up 4%, neonatal device sales were up 11%, gynecology/ electrosurgery device sales were down 7% and obstetrics device sales were down 9%. For 1H 2010 compared to 1H 2009 global sales in product categories, BPM sales were up 6%, neonatal device sales were up 6%, gynecology/ electrosurgery device sales were down 4% and obstetrics device sales were down 9%.